Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

HEART Rate Variability Biofeedback in LOng COVID-19 (HEARTLOC)

  • Read more about HEART Rate Variability Biofeedback in LOng COVID-19 (HEARTLOC)

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

  • Read more about A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

Crowdsourcing an Open COVID-19 Imaging Repository for AI Research

  • Read more about Crowdsourcing an Open COVID-19 Imaging Repository for AI Research

Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO

  • Read more about Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO

Long COVID-19 and MAB Study

  • Read more about Long COVID-19 and MAB Study

Impact of COVID19 on Asthma

  • Read more about Impact of COVID19 on Asthma

Self-Management Interventions for Long COVID-19

  • Read more about Self-Management Interventions for Long COVID-19

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

  • Read more about Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19

  • Read more about The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19

Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above

  • Read more about Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 153
  • Page 154
  • Page 155
  • Page 156
  • Current page 157
  • Page 158
  • Page 159
  • Page 160
  • Page 161
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA